Moteur de recherche d’entreprises européennes
Financement de l’UE (2 321 416 €) : Dialogue entre les plaquettes et l’immunité - implications pour l’homéostasie et la défense de l’hôte Hor29/07/2019 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Dialogue entre les plaquettes et l’immunité - implications pour l’homéostasie et la défense de l’hôte
The overall aim of the IMMUNOTHROMBOSIS project is to clarify the mechanisms underlying the recently identified synergism between thrombosis and inflammation. Thrombus formation and inflammation are vital host responses that ensure homeostasis, but can also drive cardiovascular disease, including myocardial infarction and stroke, the major causes of death in Europe. My group and others discovered, that thrombosis and inflammation are not to be considered separate processes. They are tightly interrelated and synergize in immune defence, but also in inflammatory and thrombotic diseases in a process we termed immunothrombosis. Targeting this synergism has great potential to identify innovative and unconventional strategies to more specifically prevent undesired activation of thrombotic and inflammatory pathways. However, this requires a deeper mechanistic understanding of immunothrombosis. I recently identified two ground-breaking novel immunothrombotic principles: I discovered that platelets have the ability to migrate autonomously, which assists immune cells in fighting pathogens. Further, I revealed that immune cells play a central role in controlling the production of platelets from their megakaryocyte precursors. The physiological and pathophysiological relevance of both processes is unclear. This is the starting point and focus of the IMMUNOTHROMBOSIS project. My aim is to define how platelets use their ability to migrate to support immune cells in protection of vascular integrity (objective 1) and to identify the contribution of platelet migration to different cardiovascular diseases involving immunothrombotic tissue damage (objective 2). Finally, I will clarify how inflammatory responses feedback to the production of thrombotic effectors and dissect inflammatory mechanisms that control platelet production (objective 3). IMMUNOTHROMBOSIS will identify new options for specific prevention or treatment of thrombotic and inflammatory cardiovascular diseases.
| LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN | 2 321 416 € |
https://cordis.europa.eu/project/id/833440
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : Ludwig-Maximilians-Universität München, Munich, Allemagne.
Les visualisations de "LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN - Financement de l’UE (2 321 416 €) : Dialogue entre les plaquettes et l’immunité - implications pour l’homéostasie et la défense de l’hôte"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
